12 reports

  • Antisense Therapeutics Ltd - Threats
  • Antisense Therapeutics Ltd - Strengths
  • Antisense
  • Biological Therapy
  • Netherlands
  • Company Financials
  • Antisense Therapeutics Limited
  • JUL 24, 2012: ANTISENSE PHARMA RECEIVES FDA ORPHAN DRUG DESIGNATION FOR TRABEDERSEN TO TREAT MALIGNANT MELANOMA
  • MAR 01, 2016: ONCOTELIC PRESENTS TREATMENT WITH TRABEDERSEN- AN ANTI-TGF-BETA-2 ANTISENSE- PRIMED TUMORS TO SUBSEQUENT CHEMOTHERAPIES
  • Antisense
  • Brain Cancer
  • Ophthalmology
  • World
  • Isarna Therapeutics GmbH
  • Antisense Therapeutics Limited Overview
  • Antisense Therapeutics Limited Snapshot
  • Antisense
  • Europe
  • World
  • Product Initiative
  • Antisense Therapeutics Limited
  • Sources of Capital: Antisense Therapeutics Limited
  • Profitability Analysis: Antisense Therapeutics Limited
  • Antisense
  • United States
  • World
  • Company Financials
  • Antisense Therapeutics Limited
  • ANTISENSE THERAPEUTICS LIMITED
  • JUN 17, 2016: ANTISENSE THERAPEUTICS PROVIDES UPDATE ON ATL1102 FOR MULTIPLE SCLEROSIS
  • Antisense
  • Monoclonal Antibody
  • Neurological Disorder
  • Therapy
  • AB Science SA
  • Ionis Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2016
  • Ionis Pharmaceuticals, Inc. - Company Statement
  • Antisense
  • Pharmaceutical
  • Research And Development
  • United States
  • Ionis Pharmaceuticals, Inc.
  • JUN 04, 2012: ANTISENSE PHARMA PRESENTS TRABEDERSEN PHASE I/II COMPLETE DATA AT ASCO ANNUAL MEETING
  • MAR 01, 2016: ONCOTELIC PRESENTS TREATMENT WITH TRABEDERSEN- AN ANTI-TGF-BETA-2 ANTISENSE- PRIMED TUMORS TO SUBSEQUENT CHEMOTHERAPIES
  • Antisense
  • Brain Cancer
  • Ophthalmology
  • World
  • Isarna Therapeutics GmbH

Table of Contents ## List of Tables ## List of Figures ## Antisense Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 ## Antisense Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 ## Antisense Therapeutics

  • Antisense
  • Biological Therapy
  • Therapy
  • M&A

Antisense Therapeutics Limited (ANP) - Financial and Strategic SWOT Analysis Review Table of Contents Table of Contents ## Section ## - About the Company ## Antisense Therapeutics Limited - Key Facts ## Antisense Therapeutics Limited - Key Employees ## Antisense Th

  • Antisense
  • Biological Therapy
  • Therapy
  • ANTISENSE RNAI OLIGONUCLEOTIDES FOR LIVER DISEASES
  • ANTISENSE RNAI OLIGONUCLEOTIDE FOR LIVER FIBROSIS
  • Antisense
  • Oligonucleotide
  • Pharmaceutical
  • Research And Development
  • Dicerna Pharmaceuticals, Inc.
  • ANTISENSE RNAI OLIGONUCLEOTIDE FOR LIVER FIBROSIS - DRUG PROFILE
  • ANTISENSE RNAI OLIGONUCLEOTIDE FOR LIVER FIBROSIS - DRUG PROFILE
  • Antisense
  • United States
  • World
  • Product Initiative
  • Galectin Therapeutics Inc.
  • Isis Pharmaceuticals, Inc. - Company Statement

It is an antisense oligonucleotide developed based on antisense technology.

  • Antisense
  • Pharmaceutical
  • Research And Development
  • United States
  • Isis Pharmaceuticals, Inc.